John Wilkin
Stock Analyst at Craig-Hallum
(2.80)
# 1,567
Out of 5,102 analysts
5
Total ratings
60%
Success rate
37.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $7.21 | +66.44% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $15.42 | -2.72% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $42.22 | +6.58% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $9.28 | -13.79% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $7.30 | +297.26% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $7.21
Upside: +66.44%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $15.42
Upside: -2.72%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $42.22
Upside: +6.58%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $9.28
Upside: -13.79%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $7.30
Upside: +297.26%